FELODIPINE

Post-LOESM

felodipine

ANDAORALTABLET, EXTENDED RELEASE
Approved
Oct 2018
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
5

Mechanism of Action

Calcium Channel Antagonists

Pharmacologic Class:

Dihydropyridine Calcium Channel Blocker

Clinical Trials (5)

NCT01520285Phase 4Completed

Compare the Effects of Lercanidipine Hydrochloride Tablet (Zanidip®) and Felodipine Sustained-Release Tablet for Hypertension

Started Dec 2011
281 enrolled
Hypertension
NCT00905333Phase 1Completed

Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal

Started Oct 2008
36 enrolled
Healthy
NCT00507845Phase 4Completed

Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina

Started Jun 2007
271 enrolled
Hypertension
NCT02336607N/ACompleted

The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.

Started Dec 2005
529 enrolled
Hypertension
NCT00367939Phase 3Completed

Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine

Started Dec 2005
132 enrolled
Hypertension